Learn about EY Biotech

You’ve got the biotech know-how, the ideas that will shape tomorrow’s world. But there are some challenges as you progress from pre-clinical to clinical and on to your eventual commercial breakthrough. Draw on the expertise you need early on in your journey. Our support continuously adapts to your requirements.

We have the multidisciplinary expertise to take your business venture to the next level – from operations and talent management to tax and capital markets support and being ready for a transaction. Learn more about the multifaceted business solutions we can offer you across all stages of your growth journey. With a package of services that grows as you grow – we have you covered!

Have we sparked your interest? We are looking forward to hearing from you.


ey-440201-2nd-graph-final-teams.png

EY Biotech - Multifaceted support from a single source

As an emerging biotech company, you are constantly facing new challenges such as looking for the next financing round, adapting to a shifting regulatory environment or meeting growing operational demands. Timely and reliable support at the right moment is paramount for commercial success. So why not partner from the outset with the best in every discipline that counts? We can help you avoid the common pitfalls, overcome unforeseen challenges, and identify unsuspected opportunities. EY offers you competent support specifically adapted to your current situation, so that can you stay ahead of the curve.

Our experienced team of experts specialized in the life sciences sector can offer your bespoke business support in all phases of your venture’s lifecycle. Partner with specialists who adapt to your current situation and anticipate the next step on your journey! Backed by our global network, we can offer you the multidisciplinary support you need, when you need it, wherever in the world you need it – all from a single source.

Take a closer look at the solutions we have specifically put together for the biotech sector and find out how we can accompany your unique growth journey.

EY Firepower report: life sciences dealmaking – trends in 2025

Life sciences dealmaking volume is stable, but value is down – how will smaller, smarter deals help to ensure a more confident future?

Related articles

The Basel Area Life Sciences Ecosystem in a Global Landscape

What do life science companies need to thrive and how does the Basel Area life sciences ecosystem compare internationally? Read our study to find out.

    Latest news

    Swiss Biotech Report 2024 shows sector performing well in 2023 by continuing to embrace international alliances

    During 2023, Switzerland’s biotech sector again demonstrated considerable agility particularly in commercialization and financing activities to continue to play a key role in driving global healthcare innovation. In addition to record revenues of CHF 7.3 billion, the industry raised more than CHF 2 billion – a remarkable 50% increase over 2022.

    23 Apr 2024 EY Switzerland

    Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role

    During 2022, Switzerland’s biotech industry again showed its resilience by adjusting to geopolitical disruptions while continuing to play a key role in driving global healthcare innovation.

    25 Apr 2023 EY Switzerland
      Contact us
      Interested in the changes we have made here,
      contact us to find out more.
      You are visiting EY ch (en)
      ch en